[Thrombolytic treatment of arteriopathies. Do thrombolytics compete with surgery?].
D000328:Adult; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D002404:Catheterization / Q000009:adverse effects; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006470:Hemorrhage / Q000150:complications; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D010446:Peptide Fragments / Q000627:therapeutic use; D010958:Plasminogen / Q000627:therapeutic use; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D010446:Peptide Fragments; C018998:lysyl-plasminogen; D010958:Plasminogen; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
Traitement thrombolytique des artériopathies. Les thrombolytiques concurrencent-ils la chirurgie?